Every SEC filing alert our engine sent, newest first: 8-K material events, deals, capital raises, leadership changes, results and insider buying and selling.
For the nine months ended September 30, 2026, Sound Point Direct Lending BDC reported total investment income of $21.3 million and net investment income of $9.8 million. The company's net asset value per share increased to $25.03 from $24.81 at the end of 2025, driven by a net increase in net assets from operations of $11.0 million.
Eloxx Pharmaceuticals is a clinical-stage biotechnology company focused on developing exaluren for Alport Syndrome and ADPKD. The company reports significant operating losses and indicates a substantial need for additional funding to continue as a going concern and maintain its Nasdaq listing.
Nakamoto Inc. entered into an amended and restated sales agreement to maintain an at-the-market (ATM) offering program for up to $4.99 billion of common stock. The amendment updates the group of sales agents, adding Muriel Siebert & Co., LLC and Maxim Group LLC while terminating the participation of several previous agents.
NexPoint Capital, Inc. announced that its net asset value (NAV) per share was determined to be $3.79 as of November 11, 2026. This figure also serves as the price for shares issued under the company's distribution reinvestment plan (DRP).
Abbott Laboratories extended the term of its Change in Control Agreements for its named executive officers through December 31, 2028. The agreement for Chairman and CEO Robert B. Ford was not extended and is set to expire on December 31, 2026.
Better Home & Finance Holding Announces $30M Stock Buyback
The Board of Directors authorized a new program to purchase call options and sell put options on its Class A common stock as part of its existing $30 million stock buyback program. The options program will start with an initial net cash expenditure limit of $1.0 million and is intended to enhance the company's capital allocation strategy.
Energy Fuels Inc. has filed an updated investor presentation following its Q3 2026 financial results and the completion of its acquisition of Australian Strategic Materials Ltd. (ASM). The presentation provides updated strategic highlights and operational data for investors following these major corporate milestones.
MSD Investment Corp. reported total assets of $7.48 billion as of September 30, 2026, with a net asset value per share of $23.54. The company increased its total debt to $3.82 billion, primarily driven by higher utilization of its revolving credit facility and the issuance of unsecured notes.
Figure Technology Solutions, Inc. has committed to providing financial support to Figure Certificate Company to ensure it can satisfy all obligations and debt service requirements through at least December 31, 2027. Additionally, the Parent company has agreed to waive repayment of all existing and future loans, advances, and operating expenses incurred by the Company during this period.
Macquarie Energy Transition Infrastructure Fund, L.P. reported total assets of $209.1 million as of September 30, 2026, a significant increase from $132.7 million in March 2026, primarily driven by investments in affiliated funds. The fund operates as an emerging growth company and reported 1,052,536 Class E units and 449,610 Class I units outstanding as of the period end.
Capital One Financial Corporation disclosed its monthly credit performance metrics for October 2026, reporting a 4.02% net charge-off rate for its domestic credit card business. The company also reported a 30+ day performing delinquency rate of 3.87% for credit cards and 4.68% for its auto loan portfolio.
Viking Therapeutics is advancing its obesity pipeline with VK2735 showing 22% weight loss at 33 weeks and promising maintenance data, while preparing for 2028 oral data.
Nexgel Interim CEO Brian Joseph Kieser Buys $733K of Stock
Brian Joseph Kieser, Interim CEO, bought 133,216 shares of Nexgel, Inc. at $5.50 a share, worth $733K in total on Nov 10, 2026. Shares held after the trade: 133,216.
Nexgel Insider steven mark glassman Buys $25K of Stock
steven mark glassman bought 4,546 shares of Nexgel, Inc. at $5.50 a share, worth $25K in total on Nov 10, 2026. Shares held after the trade: 12,379 (+58.0%).
Neuronetics Insider Jorey Chernett Buys $79.6K of Stock
Jorey Chernett bought 40,000 shares of Neuronetics, Inc. at $1.99 a share, worth $79.6K in total on Nov 9, 2026. Shares held after the trade: 10,306,225 (+0.4%).
Neuronetics Insider Jorey Chernett Sells $4.48M of Stock
Jorey Chernett sold 3,335,411 shares of Neuronetics, Inc. at $1.15 to $2.39 a share (average $1.34) in 5 transactions, worth $4.48M in total between Nov 6, 2026 and Nov 13, 2026. Shares held after the trade: 7,325,577 (-23.0%).
Exagen Insider Jorey Chernett Sells $746K of Stock
Jorey Chernett sold 167,504 shares of Exagen Inc. at $4.08 to $4.65 a share (average $4.45) in 2 transactions, worth $746K in total between Nov 12, 2026 and Nov 13, 2026. Shares held after the trade: 2,529,436 (-2.2%).
Vivani Medical Chief Business Officer Donald Dwyer Buys $15.5K of Stock
Donald Dwyer, Chief Business Officer, bought 15,000 shares of Vivani Medical, Inc. at $1.03 a share, worth $15.5K in total on Nov 12, 2026. Shares held after the trade: 75,000 (+25.0%).
Fair Isaac President and CEO William J. Lansing Sells $184K of Stock
William J. Lansing, President and CEO, sold 250 shares of Fair Isaac Corp at $735.00 a share, worth $184K in total on Nov 12, 2026. Shares held after the trade: 0 (-100.0%).
Fair Isaac President and CEO William J. Lansing Sells $14.8M of Stock
William J. Lansing, President and CEO, sold 20,465 shares of Fair Isaac Corp at $715.51 to $732.00 a share (average $723.31) in 28 transactions, worth $14.8M in total between Nov 11, 2026 and Nov 12, 2026. Shares held after the trade: 250 (-28.2%).
Starwood Property Trust Director Jonathan Lee Pollack Buys $2.01M of Stock
Jonathan Lee Pollack, Director, bought 169,800 shares of Starwood Property Trust, Inc. at $11.84 to $11.88 a share (average $11.86) in 2 transactions, worth $2.01M in total on Nov 11, 2026. Shares held after the trade: 84,800.
Starwood Property Trust CEO, Chairman of the Board Barry S. Sternlicht Buys $14.7M of Stock
Barry S. Sternlicht, CEO, Chairman of the Board, bought 1,245,000 shares of Starwood Property Trust, Inc. at $11.59 to $11.91 a share (average $11.81) in 2 transactions, worth $14.7M in total between Nov 11, 2026 and Nov 12, 2026. Shares held after the trade: 1,498,421 (+38.3%).
Natera Director Jonathan Sheena Sells $479K of Stock
Jonathan Sheena, Director, sold 1,500 shares of Natera, Inc. at $315.26 to $324.76 a share (average $319.30) in 14 transactions, worth $479K in total on Nov 11, 2026. Shares held after the trade: 7,500 (-0.5%).
LifeStance Health Group Insider Ryan Pardo Sells $40.9M of Stock
Ryan Pardo sold 2,804,505 shares of LifeStance Health Group, Inc. at $14.58 a share, worth $40.9M in total on Nov 10, 2026. Shares held after the trade: 334,935 (-86.9%).
Alamar Biosciences 10% Owner Qiming Corporate GP VI Ltd. Sells $2.94M of Stock
Qiming Corporate GP VI Ltd., 10% Owner, sold 100,061 shares of Alamar Biosciences, Inc. at $29.34 to $30.63 a share (average $29.38) in 7 transactions, worth $2.94M in total on Nov 11, 2026. Shares held after the trade: 1,632,188 (-0.0%).
Live Nation Entertainment EVP, M&A and Strategic Finance John Hopmans Sells $2.01M of Stock
John Hopmans, EVP, M&A and Strategic Finance, sold 11,133 shares of Live Nation Entertainment, Inc. at $180.50 a share, worth $2.01M in total on Nov 13, 2026. Shares held after the trade: 163,299 (-6.4%).
Live Nation Entertainment President & CFO Joe Berchtold Sells $16.7M of Stock
Joe Berchtold, President & CFO, sold 93,537 shares of Live Nation Entertainment, Inc. at $178.21 to $180.03 a share (average $178.84) in 3 transactions, worth $16.7M in total on Nov 13, 2026. Shares held after the trade: 901,617 (-1.1%).
MediaAlpha CTO Kuanling Amy Yeh Sells $176K of Stock
Kuanling Amy Yeh, CTO, sold 12,000 shares of MediaAlpha, Inc. at $14.69 a share, worth $176K in total on Nov 13, 2026. Shares held after the trade: 481,091 (-2.4%).
indie Semiconductor Director David J. Aldrich Buys $299K of Stock
David J. Aldrich, Director, bought 130,000 shares of indie Semiconductor, Inc. at $2.30 a share, worth $299K in total on Nov 11, 2026. Shares held after the trade: 393,392 (+49.4%).
Oruka Therapeutics SVP, Finance Arjun Agarwal Sells $1.05M of Stock
Arjun Agarwal, SVP, Finance, sold 10,000 shares of Oruka Therapeutics, Inc. at $101.98 to $107.00 a share (average $104.97) in 6 transactions, worth $1.05M in total on Nov 12, 2026. Shares held after the trade: 14,219 (-0.7%).